ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 980 filers reported holding ASTRAZENECA PLC in Q1 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,837,420 | +14.2% | 49,204 | -0.8% | 0.14% | +8.4% |
Q1 2024 | $3,358,842 | -6.0% | 49,577 | -6.5% | 0.13% | -14.4% |
Q4 2023 | $3,571,907 | +14.9% | 53,035 | +15.5% | 0.15% | -11.0% |
Q3 2023 | $3,110,041 | +21.2% | 45,925 | +28.1% | 0.17% | +24.6% |
Q2 2023 | $2,565,427 | -2.3% | 35,845 | -5.2% | 0.14% | -14.8% |
Q1 2023 | $2,625,780 | +0.7% | 37,830 | -1.6% | 0.16% | -4.1% |
Q4 2022 | $2,606,978 | +29.3% | 38,451 | +4.6% | 0.17% | +16.6% |
Q3 2022 | $2,016,000 | -22.0% | 36,769 | -6.0% | 0.14% | -11.6% |
Q2 2022 | $2,584,000 | -16.4% | 39,106 | -16.0% | 0.16% | +26.2% |
Q1 2022 | $3,090,000 | +239.2% | 46,577 | +197.7% | 0.13% | +333.3% |
Q4 2021 | $911,000 | -2.9% | 15,646 | +0.2% | 0.03% | -6.2% |
Q3 2021 | $938,000 | +4.7% | 15,610 | +4.4% | 0.03% | +6.7% |
Q2 2021 | $896,000 | +23.8% | 14,959 | +2.7% | 0.03% | +7.1% |
Q1 2021 | $724,000 | +3.1% | 14,562 | +3.7% | 0.03% | -9.7% |
Q4 2020 | $702,000 | +0.9% | 14,048 | +10.7% | 0.03% | -13.9% |
Q3 2020 | $696,000 | -19.3% | 12,693 | -22.1% | 0.04% | -25.0% |
Q2 2020 | $862,000 | +44.6% | 16,294 | +22.2% | 0.05% | +6.7% |
Q1 2020 | $596,000 | -31.4% | 13,338 | -23.4% | 0.04% | +18.4% |
Q4 2019 | $869,000 | -10.9% | 17,423 | -20.3% | 0.04% | -22.4% |
Q3 2019 | $975,000 | -4.7% | 21,867 | -11.8% | 0.05% | 0.0% |
Q2 2019 | $1,023,000 | +3.5% | 24,788 | +1.4% | 0.05% | +2.1% |
Q1 2019 | $988,000 | +27.3% | 24,444 | +19.6% | 0.05% | 0.0% |
Q4 2018 | $776,000 | -31.4% | 20,437 | -28.5% | 0.05% | +11.6% |
Q3 2018 | $1,132,000 | +10.8% | 28,600 | -1.7% | 0.04% | +4.9% |
Q2 2018 | $1,022,000 | -4.8% | 29,100 | -5.2% | 0.04% | -4.7% |
Q1 2018 | $1,074,000 | -44.3% | 30,700 | -44.8% | 0.04% | -41.9% |
Q4 2017 | $1,929,000 | -8.3% | 55,600 | -10.4% | 0.07% | -15.9% |
Q3 2017 | $2,104,000 | +36.1% | 62,088 | +36.9% | 0.09% | +25.7% |
Q2 2017 | $1,546,000 | -13.8% | 45,344 | -21.3% | 0.07% | -12.5% |
Q1 2017 | $1,794,000 | +72.0% | 57,616 | +51.0% | 0.08% | +66.7% |
Q4 2016 | $1,043,000 | -13.5% | 38,168 | +4.0% | 0.05% | -15.8% |
Q3 2016 | $1,206,000 | +18.6% | 36,708 | +9.0% | 0.06% | +14.0% |
Q2 2016 | $1,017,000 | -14.3% | 33,672 | -20.1% | 0.05% | -19.4% |
Q1 2016 | $1,187,000 | -12.2% | 42,136 | +5.8% | 0.06% | -3.1% |
Q4 2015 | $1,352,000 | +24.5% | 39,836 | +16.7% | 0.06% | +3.2% |
Q3 2015 | $1,086,000 | -33.8% | 34,132 | +32.5% | 0.06% | -8.8% |
Q2 2015 | $1,641,000 | -4.7% | 25,760 | +2.4% | 0.07% | +1.5% |
Q1 2015 | $1,722,000 | +20.3% | 25,162 | +23.8% | 0.07% | +13.6% |
Q4 2014 | $1,431,000 | -19.2% | 20,332 | -18.0% | 0.06% | -28.9% |
Q3 2014 | $1,771,000 | -38.7% | 24,786 | -36.2% | 0.08% | -34.6% |
Q2 2014 | $2,889,000 | +38.8% | 38,880 | +21.2% | 0.13% | +33.7% |
Q1 2014 | $2,081,000 | +3.7% | 32,076 | -5.1% | 0.10% | +5.6% |
Q4 2013 | $2,007,000 | +30.7% | 33,804 | +14.3% | 0.09% | +11.1% |
Q3 2013 | $1,535,000 | +99.1% | 29,563 | +81.3% | 0.08% | +50.0% |
Q2 2013 | $771,000 | – | 16,309 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |